Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -17.712\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) COc1ccc(NC(=O)/C=C/c2c(Cl)nc3ccccn23)cc1
(b) O=C1Nc2cc(Cl)c(Cl)cc2N(O)N1c1ccc(Cl)cc1
(c) Cc1ccc2cc(CCNC(=O)c3cccc([N+](=O)[O-])c3)c(=O)[nH]c2c1
Answer: a. COc1ccc(NC(=O)/C=C/c2c(Cl)nc3ccccn23)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)/C=C/c2c(Cl)nc3ccccn23)cc1
COc1ccc(NC(=O)/C=C/c2c(Cl)nc3ccccn23)cc1
(E)-3-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-(4-methoxyphenyl)prop-2-enamide